Skip to content

A Proof-of-Concept Study to Explore the Potential Efficacy of Deferiprone in Patients With Pelizaeus-Merzbacher disease (PMD)

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-511968-81-00
Acronym
74668
Enrollment
10
Registered
2024-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelizaeus-Merzbacher disease

Brief summary

Motor function as measured by the gross motor function measurement tool (GMFM-88). (Paulson and Vargus-Adams, 2017) and using the GMF scoring for metachromatic leukodystrophy, MLD-GMF score (Kehrer et al., 2011)

Detailed description

Quantitative brain MRI parameters: Diffusion Tensor Imaging (DTI); Chemical Shift Imaging (CSI); Neurite Orientation Dispersion and Density Imaging (NODDI); Density Imaging (NODDI); Myelin Water Fraction Imaging (MWFI), Electrophysiological parameters: EEG, Clinical parameters: General health and quality of life: Health Utility Index (HUI); Hand function: Manual Ability Classification System (MACS); Manual Ability Classification System (MACS); Communication Function Classification System (CFCS); Swallowing function: Eating and Drinking Ability Classification System (EDACS); Euro-Quality of Life Instrument 5D, 5 levels (EQ-5D-Y, proxy); Vineland Adaptive Behavior Scales, 3rd edition (Vineland-3)

Interventions

DRUGFerriprox 100 mg/ml oral solution

Sponsors

Amsterdam UMC Stichting
Lead SponsorOTHER

Eligibility

Sex/Gender
Male
Age
0 Years to 17 Years

Design outcomes

Primary

MeasureTime frame
Motor function as measured by the gross motor function measurement tool (GMFM-88). (Paulson and Vargus-Adams, 2017) and using the GMF scoring for metachromatic leukodystrophy, MLD-GMF score (Kehrer et al., 2011)

Secondary

MeasureTime frame
Quantitative brain MRI parameters: Diffusion Tensor Imaging (DTI); Chemical Shift Imaging (CSI); Neurite Orientation Dispersion and Density Imaging (NODDI); Density Imaging (NODDI); Myelin Water Fraction Imaging (MWFI), Electrophysiological parameters: EEG, Clinical parameters: General health and quality of life: Health Utility Index (HUI); Hand function: Manual Ability Classification System (MACS); Manual Ability Classification System (MACS); Communication Function Classification System (CFCS); Swallowing function: Eating and Drinking Ability Classification System (EDACS); Euro-Quality of Life Instrument 5D, 5 levels (EQ-5D-Y, proxy); Vineland Adaptive Behavior Scales, 3rd edition (Vineland-3)

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026